SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank57
3Y CAGR-25.9%
5Y CAGR-49.1%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

3Y CAGR
-25.9%/yr
Annual compound
5Y CAGR
-49.1%/yr
Recent acceleration
Percentile
P57
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202520.24%
2024245.65%
2023-61.63%
202249.78%
2021-0.25%
2020593.20%
2019-152.22%
2018-42.57%
20170.07%
201614.58%